We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
47 hedge funds and large institutions have $215M invested in Intra-Cellular Therapies Inc. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more capital invested
Capital invested by funds: $166M → $215M (+$49.7M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
4% less funds holding
Funds holding: 49 → 47 (-2)
Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
16
Reduced
17
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.15M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$781K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$689K |
| 4 |
Morgan Stanley
New York
|
+$466K |
| 5 |
State Street
Boston,
Massachusetts
|
+$247K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$952K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$515K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$198K |
| 4 |
Goldman Sachs
New York
|
-$149K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$140K |
